Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$3.25M Buy
1,096,406
+161,896
+17% +$671K 7.45% 3
2022
Q3
$5.19M Buy
934,510
+20,000
+2% +$121K 10.54% 2
2022
Q2
$5.95M Buy
914,510
+18,851
+2% +$132K 12.21% 1
2022
Q1
$6.63M Sell
895,659
-53,341
-6% -$334K 9.75% 3
2021
Q4
$5.68M Buy
949,000
+107,987
+13% +$757K 4.37% 12
2021
Q3
$6.43M Buy
841,013
+141,013
+20% +$1.14M 4.64% 12
2021
Q2
$6.06M Buy
700,000
+261,240
+60% +$2.02M 4.13% 12
2021
Q1
$3.19M Buy
+438,760
New +$3.42M 2.35% 16

Other funds holding LNSR

North Run Capital's LNSR Position: Q4 2022 in Review

North Run Capital increased its LENSAR (LNSR) stake by 17% in Q4 2022, buying an estimated $671K and bringing the position to 1,096,406 shares worth $3.25M. The position accounts for 7.45% of the portfolio, ranked #3.

North Run Capital first reported a position in LNSR in Q1 2021 and has held it in 8 quarters since. The position peaked at $6.63M in Q1 2022. 33 funds tracked by Wall St. Rank hold LNSR as of Q4 2022.

  • North Run Capital held 1,096,406 shares of LENSAR worth $3.25M as of Q4 2022.
  • North Run Capital bought 161,896 LENSAR shares in Q4 2022, an estimated $671K.
  • LENSAR made up 7.45% of North Run Capital's portfolio in Q4 2022, its #3 holding.
  • North Run Capital first reported a position in LENSAR in Q1 2021 and has held it in 8 quarters since.
  • North Run Capital's LENSAR position peaked at $6.63M in Q1 2022.
  • 33 funds tracked by Wall St. Rank held LENSAR as of Q4 2022.

Based on North Run Capital's 13F filing for Q4 2022, filed 14 Feb 2023.